IQVIA Holdings | IQV - Des Atouts





Des Atouts Changement Date
Accenture USD 68.81B 1.74B 2026-03
Agilent USD 13.07B 252M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Cardinal Health USD 56.69B 1.39B 2026-03
Celltrion KRW 768.81B 9.37B 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Cigna USD 153.27B 4.65B 2026-03
Cognizant Technology Solutions USD 20.5B 192M 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
CVS Health USD 252.97B 564M 2026-03
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.23B 200M 2026-03
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Elevance Health USD 126.44B 611M 2026-06
Humana USD 55.28B 6.37B 2026-03
IBM USD 156.23B 4.35B 2026-03
Illumina USD 6.56B 85M 2026-03
Infosys INR 1.43T 169.96B 2025-12
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Laboratory Of America USD 19.09B 694.4M 2026-03
Malin Corporation EUR 198.5M 70.1M 2024-12
McKesson USD 82.32B 1.87B 2026-03
Mettler Toledo International USD 3.67B 43.73M 2026-03
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pharma Mar EUR 385.26M 9.82M 2026-03
Publicis EUR 40.14B 128M 2026-06
Qiagen NV USD 6.3B 257.54M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Revvity USD 12B 171.82M 2026-03
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Tilray USD 2.1B 15.95M 2025-09
UnitedHealth USD 309.73B 2.92B 2026-06
Veeva Systems USD 9.13B 150.22M 2026-03
Veradigm USD 1.5B 185.94M 2022-12
Waters USD 24.53B 19.45B 2026-03
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03